Pentixapharm Holding AG (PTP) NPV

Sell:€4.11Buy:€4.22€0.06 (1.27%)

Prices delayed by at least 15 minutes
Sell:€4.11
Buy:€4.22
Change:€0.06 (1.27%)
Deal now
Prices delayed by at least 15 minutes
Sell:€4.11
Buy:€4.22
Change:€0.06 (1.27%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Pentixapharm Holding AG is a Germany-based clinical-stage radiopharmaceutical development company. The Company focuses on the development of radiopharmaceuticals for various therapeutic areas, as well as for the diagnosis and therapy (theranostics) of blood cancer and others. It is also engaged in holding activities and is also involved in the research and development of drugs for hematological and solid cancers, as well as cardiovascular, endocrine and inflammatory diseases.

Key people

Andreas Eckert
Chairman of the Supervisory Board
Hakim Bouterfa
Chief Executive Officer, Member of the Management Board
Harald Hasselmann
Deputy Chairman of the Supervisory Board
Jens Giltsch
Member of the Supervisory Board
Ken Herrmann
Member of the Supervisory Board
Click to see more

Key facts

  • EPIC
    -
  • Location
    Germany
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    DE000A40AEG0
  • Market cap
    €105.63m
  • Employees
    -
  • Shares in issue
    24.80m
  • Exchange
    XETRA
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.